Cargando…
Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm)
PURPOSE: Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) has some limitations such as poor sonic window and injury to adjacent organs. The laparoscopic approach has been suggested as an alternative option. The aim of this study was to show the safety and efficacy of lap...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416922/ https://www.ncbi.nlm.nih.gov/pubmed/28480181 http://dx.doi.org/10.4174/astr.2017.92.5.355 |
_version_ | 1783233846553083904 |
---|---|
author | Na, Byung Gon Kim, Jong Man Oh, Dong Kyu Lee, Kyo-Won Kang, Tae-Wook Choi, Gyu-Seong Lee, Min Woo Kwon, Choon Hyuck David Lim, Hyun Chul Joh, Jae-Won |
author_facet | Na, Byung Gon Kim, Jong Man Oh, Dong Kyu Lee, Kyo-Won Kang, Tae-Wook Choi, Gyu-Seong Lee, Min Woo Kwon, Choon Hyuck David Lim, Hyun Chul Joh, Jae-Won |
author_sort | Na, Byung Gon |
collection | PubMed |
description | PURPOSE: Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) has some limitations such as poor sonic window and injury to adjacent organs. The laparoscopic approach has been suggested as an alternative option. The aim of this study was to show the safety and efficacy of laparoscopic RFA for single, small (≤3 cm), and primary or recurrent HCC that is not suitable for percutaneous RFA or surgical resection. METHODS: We reviewed the cases of 37 patients (32 men and 5 women, mean age 61 ± 8.1 years) who underwent laparoscopic RFA for single, small HCC (≤3 cm) that was unsuitable for percutaneous RFA or surgical resection. RESULTS: The technical success rate was 94.6% and 34 patients (95%) had no complications. There were no conversions to open RFA and no operative mortality. The primary effectiveness rate 1 month after the procedure was 100%. The overall recurrence rates at 3, 6, 12, and 24 months after the laparoscopic RFA were 8.1%, 14.4%, 25%, and 35.7%, respectively. The local tumor progression rate was 4.2% at 6 months and 8.7% at 9 months. CONCLUSION: Laparoscopic RFA is a safe and effective treatment for HCC cases that are unsuitable for percutaneous RFA. |
format | Online Article Text |
id | pubmed-5416922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Surgical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-54169222017-05-06 Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) Na, Byung Gon Kim, Jong Man Oh, Dong Kyu Lee, Kyo-Won Kang, Tae-Wook Choi, Gyu-Seong Lee, Min Woo Kwon, Choon Hyuck David Lim, Hyun Chul Joh, Jae-Won Ann Surg Treat Res Original Article PURPOSE: Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) has some limitations such as poor sonic window and injury to adjacent organs. The laparoscopic approach has been suggested as an alternative option. The aim of this study was to show the safety and efficacy of laparoscopic RFA for single, small (≤3 cm), and primary or recurrent HCC that is not suitable for percutaneous RFA or surgical resection. METHODS: We reviewed the cases of 37 patients (32 men and 5 women, mean age 61 ± 8.1 years) who underwent laparoscopic RFA for single, small HCC (≤3 cm) that was unsuitable for percutaneous RFA or surgical resection. RESULTS: The technical success rate was 94.6% and 34 patients (95%) had no complications. There were no conversions to open RFA and no operative mortality. The primary effectiveness rate 1 month after the procedure was 100%. The overall recurrence rates at 3, 6, 12, and 24 months after the laparoscopic RFA were 8.1%, 14.4%, 25%, and 35.7%, respectively. The local tumor progression rate was 4.2% at 6 months and 8.7% at 9 months. CONCLUSION: Laparoscopic RFA is a safe and effective treatment for HCC cases that are unsuitable for percutaneous RFA. The Korean Surgical Society 2017-05 2017-04-27 /pmc/articles/PMC5416922/ /pubmed/28480181 http://dx.doi.org/10.4174/astr.2017.92.5.355 Text en Copyright © 2017, the Korean Surgical Society http://creativecommons.org/licenses/by-nc/4.0/ Annals of Surgical Treatment and Research is an Open Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Na, Byung Gon Kim, Jong Man Oh, Dong Kyu Lee, Kyo-Won Kang, Tae-Wook Choi, Gyu-Seong Lee, Min Woo Kwon, Choon Hyuck David Lim, Hyun Chul Joh, Jae-Won Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
title | Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
title_full | Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
title_fullStr | Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
title_full_unstemmed | Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
title_short | Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
title_sort | clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm) |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416922/ https://www.ncbi.nlm.nih.gov/pubmed/28480181 http://dx.doi.org/10.4174/astr.2017.92.5.355 |
work_keys_str_mv | AT nabyunggon clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT kimjongman clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT ohdongkyu clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT leekyowon clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT kangtaewook clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT choigyuseong clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT leeminwoo clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT kwonchoonhyuckdavid clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT limhyunchul clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm AT johjaewon clinicaloutcomesoflaparoscopicradiofrequencyablationofsingleprimaryorrecurrenthepatocellularcarcinoma3cm |